H36.829
H36.829 — Proliferative sickle-cell retinopathy, unspecified eye
Billable / specific codeICD-10-CMunspecified
H36.829 is a billable, specific ICD-10-CM code for proliferative sickle-cell retinopathy, unspecified eye. It is valid for submission on a claim.
Risk adjustment
H36.829 risk-adjusts. Under the CMS-HCC V28 model it maps to these categories:
- HCC 108 Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major0.146 RAF
- HCC 298 Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage0.336 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
H36.829 is named in 1 Medicare coverage policy — 1 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A53008Billing and Coding: Intraocular Bevacizumab
Related codes at this level
Codes that share H36.82. If H36.829 is not quite right, the correct code is usually one of these.
Questions about H36.829
- Is H36.829 a billable ICD-10-CM code?
- Yes. H36.829 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does H36.829 sit in the tabular list?
- Diseases of the eye and adnexa (H00-H59), in the block Disorders of choroid and retina (H30-H36).